Michael J. Porro & Co. Financial Advisors, Inc.’s AbbVie ABBV Stock Holding History

Michael J. Porro & Co. Financial Advisors, Inc.’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$971K	Buy	+4,249	New	+$968K	0.81%	49

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Michael J. Porro & Co. Financial Advisors, Inc.'s ABBV Position: Q4 2025 in Review

Michael J. Porro & Co. Financial Advisors, Inc. opened a new position in AbbVie (ABBV) in Q4 2025: 4,249 shares worth $971K. The stake represents 0.81% of the portfolio and ranks #49 among its holdings.

4,171 funds tracked by Wall St. Rank hold ABBV as of Q4 2025.

Michael J. Porro & Co. Financial Advisors, Inc. held 4,249 shares of AbbVie worth $971K as of Q4 2025.
AbbVie was a new Michael J. Porro & Co. Financial Advisors, Inc. position in Q4 2025.
AbbVie made up 0.81% of Michael J. Porro & Co. Financial Advisors, Inc.'s portfolio in Q4 2025, its #49 holding.
4,171 funds tracked by Wall St. Rank held AbbVie as of Q4 2025.

Based on Michael J. Porro & Co. Financial Advisors, Inc.'s 13F filing for Q4 2025, filed 8 Oct 2026.